Regulation of autophagy and mTOR during Semliki Forest virus infection by Eng, Kai
DEPARTMENT OF MICROBIOLOGY, TUMOR AND CELL BIOLOGY  
Karolinska Institutet, Stockholm, Sweden 
 
 
 
 
 
REGULATION OF AUTOPHAGY AND MTOR  
DURING SEMLIKI FOREST VIRUS INFECTION 
 
 
 
Kai Eng 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stockholm 2012  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
About the cover: 
The cytoplasm-to-vacuole targeting (Cvt) pathway in yeast directs membrane from a 
mitochondrion (top right) to a forming Cvt vesicle (center) before the Cvt vesicle fuses 
with the vacuole (bottom right). The Cvt pathway shares many similarities with 
autophagy.  
Original painting by David S. Goodsell with scientific input from Daniel J. Klionsky. 
Previously published as cover art accompanying He et al. (2006) J. Cell Biol. 175:925-
935. Reproduced with kind permission from David S. Goodsell. 
 
Published by Karolinska Institutet 
Printed by Larserics Digital Print AB  
 
 
 
 
Kai Eng, 2012 
This work may be shared under the Creative Commons Attribution 3.0 Unported License. 
However, to reproduce any material attributed to other sources in this thesis, please 
contact the original authors or publishers for permission.  
 
ISBN 978-91-7457-891-1 
ABSTRACT 
 
Semliki Forest virus (SFV) infection causes dramatic changes to the infected cell. For 
example, synthesis of most cellular proteins shuts off within 4 hours. The cell launches 
an antiviral response, forms stress granules and, as we found in the work leading up to 
this thesis, accumulates autophagosomes. Studies on various host responses to viral 
infections are relevant for understanding both viral pathogenesis and innate immunity 
against viruses. 
 
In the past decade autophagy has gained prominence as a protein degradation system, 
and the autophagy field is only just beginning to understand how this cellular 
mechanism is modulated during viral infection, and what role it plays either in host cell 
defence, or in supporting viral replication. To be better equipped for studying 
autophagy, we developed a flow cytometry-based method for quantifying 
autophagosomes, in Paper I. The method was quicker and less subjective than most 
pre-existing methods. Then, in Paper II we investigated autophagy during SFV 
infection, and found that autophagosomes accumulated during infection not due to 
increased synthesis of new autophagosomes, but due to a decreased rate of degradation 
of autophagosomes. We also found that expression of the SFV glycoproteins was 
necessary for the accumulation of autophagosomes. 
 
Our work on autophagy led us to investigate the status of mTOR, a regulator of 
autophagy, during SFV infection. mTOR is normally active under nutrient rich 
conditions, and inactive under nutrient starvation conditions. In Paper III, we showed 
that SFV infection caused mTOR to remain active during nutrient starvation. Unlike the 
effect on autophagosome accumulation, this effect on mTOR did not depend on 
expression of the SFV glycoproteins. Despite the maintenance of mTOR activity in 
SFV infected cells, inhibition of mTOR activity with rapamycin had no effect on SFV 
growth rate. 
 
Collectively, the results presented in this thesis provide a novel, practical tool for 
measuring autophagy, as well as insight on how autophagy and its regulator mTOR are 
modulated during SFV infection.  
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1 INTRODUCTION 
 
1.1 SEMLIKI FOREST VIRUS 
 
1.1.1 Background 
 
Semliki Forest virus (SFV) was first isolated in the Semliki Forest of Uganda in 1942 
(131). It is an insect-borne virus, spread by mosquitoes and infecting small animals. 
The virus is neurotropic in these animals. SFV is not an important human pathogen. 
However, it is closely related to the emerging Chikungunya virus, which has recently 
caused outbreaks of severe illness in human populations.  
 
Both SFV and Chikungunya virus belong to the Alphavirus genus, family Togaviridae. 
A third Alphavirus, Sindbis virus, is also closely related to SFV. SFV and Sindbis virus 
have both been used extensively in laboratories as model viruses for studying the 
biology of viral infection, not least due to their broad host range and efficient 
replication in laboratory cell lines. In this thesis I will discuss what we have observed in 
SFV infected cells, in comparison with the published literature on Chikungunya virus 
and Sindbis virus infected cells. 
 
SFV is also well known in the biotechnology field as a viral vector for delivery of 
foreign genes for expression of heterologous proteins, potentially useful for vaccination 
or gene therapy. Systems to generate suicidal virus particles have been developed: first, 
a gene of interest is inserted, in place of the genes encoding SFV structural proteins, 
into a plasmid encoding a cDNA copy of the SFV genome, the SFV vector. (For more 
on the SFV genome, see next section.) Then, RNA from the recombinant SFV vector is 
synthesised in vitro and co-transfected into cells along with helper RNA encoding the 
SFV structural proteins. In the co-transfected cells, the packaging signal present on the 
SFV vector causes packaging of this RNA into particles. These particles are suicidal 
(causing a single round of infection only) because they do not contain the RNA that 
codes for SFV structural proteins (78). In the single-round infected cells, heterologous 
protein encoded by the vector is expressed at high levels under the control of the 
Alphavirus 26S promoter. Subsequently, an improved system was developed that 
eliminated the risk of the helper RNA recombining with the vector RNA in co-
transfected cells to generate wild type SFV RNA, by splitting the helper RNA into two 
independent RNA molecules that each coded for different SFV structural proteins 
(130). While the life cycle of SFV has been well defined, further studies on the biology 
of SFV infected cells may provide insights for future SFV-based technologies. 
 
1.1.2 Structure 
 
SFV has a positive-sense RNA genome of 11.5 kb (Figure 1). This 42S RNA genome 
is capped on the 5’ end and polyadenylated on the 3’ end. The genome is packed in an 
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icosahedral capsid. Surrounding the capsid is the SFV envelope, which is derived from 
the host cell plasma membrane. There are 80 individual glycoprotein spike complexes 
on the SFV surface, each consisting of three E1-E2 heterodimers, thus there are 240 
heterodimers altogether on the viral surface. A third protein, E3, is associated to each 
dimer. The glycoprotein spikes are anchored in the envelope by the E2 cytoplasmic 
domain, which interact with the capsid.  
 
The RNA genome has two open reading frames. The 5’ two-thirds of the genome code 
for non-structural proteins (nsPs) 1-4. The 3’ one-third, under the control of an internal 
promoter, is transcribed into a subgenomic 26S mRNA which codes for the structural 
proteins. The structural proteins traditionally include capsid, E3, E2, the 6 kDa protein 
6K, and E1. In 2008, it was discovered that frameshifting occurs within the sequence 
encoding 6K so that another protein, TransFrame protein, is also expressed (31). 
 
 
 
 
 
Figure 1 
Schematic diagram of the Semliki Forest virus (SFV) genome. The 5’ two-thirds of the genome code for 
non-structural protein 1 (nsP1)-nsP4. The 3’ one-third, under the control of an internal promoter (black 
arrow), codes for the structural proteins. 
 
1.1.3 Viral life cycle 
 
SFV enters the cell via receptor-mediated endocytosis. After SFV is endocytosed, 
acidification of the endosome causes a change in conformation of the SFV spike, which 
allows the viral envelope to fuse with the endosomal membrane (144). The E1 spike 
protein mediates this fusion. After membrane fusion, the nucleocapsid is released into 
the cytoplasm.  
 
The nucleocapsid then disassembles, and viral RNA is released into the cytoplasm. 
nsP1234 is translated immediately as a polyprotein. This polyprotein is then 
sequentially, autocatalytically, cleaved to yield the individual nsP proteins, through the 
protease activity of nsP2. Viral RNA replication takes place, with the individual nsPs 
playing various roles (summarised briefly below), at replication complexes assembled 
on membranous structures. 
 
nsP1 is the capping enzyme for viral genomic and subgenomic mRNA (2). It associates 
tightly with membranes, and is the membrane anchor for the entire viral replication 
complex. Immunofluorescence analysis shows that nsP1 is localised to plasma 
membranes as well as to intracellular membrane-associated replication complexes. 
Recent work by Spuul et al. showed that nsP1-positive replication complexes are 
delivered to the plasma membrane before class I phosphatidylinositol 3-kinase (PI3K)-
dependent endocytosis back into the cell, revealing a previously unknown large-scale 
migration of nsP1-positive replication complexes before arrival at intracellular, 
membrane-associated viral replication sites (132). Tight membrane association of nsP1 
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can be attributed to its palmitoylated cysteine residues (1), as well as to a segment of 
amino acids which has high affinity for negatively charged lipids (72), such as 
phosphatidylserines, which are abundant on the inner leaflet of the plasma membrane.  
 
nsP2 as mentioned earlier is the protease responsible for processing nsP1234 into 
individual mature proteins. Sequential cleavage by the nsP2 protease regulates the 
synthesis of negative versus positive strand RNA: nsP123 and nsP4 together promote 
transcription of negative strand RNA, while subsequent cleavage between nsP1 and 
nsP23 allows shut-off of negative strand synthesis and a switch to synthesis of positive 
strand RNA, with preference for genomic RNA. The final cleavage between nsP2 and 
nsP3 promotes preference for synthesis of the subgenomic mRNA over genomic RNA 
(65, 76). nsP2 localises both to the nucleus and to the cytoplasm. Its nuclear localisation 
signal is in its C-terminal domain (114). In a virus expressing a mutant nsP2 which 
does not translocate to the nucleus, viral spread in adult mouse brain is compromised 
(30), and synthesis of type I interferon (IFN) by host cells is increased (9). 
 
nsP3 is highly phosphorylated on serines and threonines, by cellular kinases, in its C-
terminal domain (107). Little is known about its function in viral replication. Current 
work from our research group shows that SFV nsP3 binds to GTPase activating protein 
(SH3 domain) binding protein 1, promoting the disassembly of stress granules, in SFV 
infected cells (Marc Panas, personal communication and Figure 2). Stress granules are 
discussed further in section 1.1.4. It has also been reported that the closely related 
Sindbis virus nsP3 binds to poly(ADP-ribose) (PAR) and PAR polymerase-1 (102), 
suggesting roles for nsP3 and PAR polymerase-1 in Sindbis virus RNA replication. 
 
 
 
 
 
 
 
 
 
Figure 2  
Stress granules in SFV infected cells. Mouse embryonic fibroblasts were infected with SFV and fixed 4 
hours later. The stress granule marker T-cell-restricted intracellular antigen-1 (TIA-1) localises to the 
nucleus in uninfected, nsP3 negative cells, but localises to the cytoplasm in infected, nsP3 positive cells, 
where it is either associated with GTPase activating protein (SH3 domain) binding protein 1 (G3BP1) in 
stress granules (yellow puncta, filled arrows) at an early stage of infection, or spread in a diffuse manner 
in the cytoplasm in later stages of infection. In cells where TIA-1 is diffuse in the cytoplasm, instead of 
stress granules, nsP3-G3BP1 double-positive foci are observed (purple puncta, open arrows). Microscope 
images kindly provided by Marc Panas, MTC, Karolinska Institutet. 
 
nsP4 is the RNA-dependent RNA polymerase of SFV; it has segments in its C-terminal 
domain conserved with all other RNA-dependent RNA polymerases. There are only 
low levels of nsP4 in an infected cell as it is rapidly degraded in the proteasome after it 
has matured (85). Although the same has not been shown for SFV, Sindbis virus 
nsP1234 is synthesised at low levels as a result of a leaky stop codon between nsP123 
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and nsP4 (133). 
 
After synthesis of viral genomic RNA, a switch to synthesis of subgenomic mRNA 
occurs as described earlier. The subgenomic mRNA is then translated into a capsid-p62 
(precursor of E3 and E2)-6K-E1 polypeptide that gives rise to the SFV structural 
proteins. Capsid is first autocatalytically cleaved from this polypeptide and binds to the 
packaging signal of viral genomic RNA, in the cytoplasm (35), while the remaining 
p62-6K-E1 polypeptide translocates into the endoplasmic reticulum (ER). During 
translocation, the p62-6K-E1 polypeptide is cleaved by cellular enzymes, forming a 
p62-E1 dimer. p62 is further cleaved in the Golgi complex into E3 and E2, which 
remain associated with each other (22). The resulting E1-E2 dimers, with E3 
associated, are transported to the plasma membrane.  
 
Capsid interaction with viral genomic RNA in the cytoplasm leads to the formation of 
nucleocapsids. Nucleocapsids bud out from the plasma membrane, forming progeny 
virus particles, in a process driven by interactions between the E2 cytoplasmic tail and 
the capsid protein (57, 135, 151). 
 
1.1.4 Host responses to SFV infection 
 
SFV infection triggers a potent host antiviral response. A prominent virus sensor, and 
mediator of antiviral response, is protein kinase R (PKR), which recognises 
intracellular double stranded RNA, assumed to be a replication intermediate in RNA 
virus infections. Antiviral effects of PKR are reviewed in (38). In the specific case of 
SFV infection, double stranded RNA is sensed by PKR, which causes a delay in viral 
protein production and a delay in release of viral progeny, enhancement of the type I 
IFN response, and promotion of virus clearance, even though it is not PKR that initiates 
the IFN response (6). 
 
Importantly, activated PKR phosphorylates eukaryotic translation initiation factor 2α 
(eIF2α), a component of eIF2, inhibiting mRNA translation. This often includes 
inhibition of translation of viral mRNA. Thus, to dampen IFN production and prevent 
translational inhibition, as well as to avert other antiviral effects of PKR, many viruses 
have evolved mechanisms to counter the effects of PKR (reviewed in (73)), such as 
influenza A virus non-structural protein 1 sequestering any free double stranded RNA 
(44). 
 
While PKR is a well studied double stranded RNA sensor in SFV infected cells, the 
retinoic-acid inducible gene I (RIG-I)-like receptor family plays a major role in sensing 
viral single stranded RNA bearing 5'-phosphates during infection by RNA viruses 
(110). Members of this family of sensors include RIG-I and melanoma differentiation 
associated gene 5 (reviewed in (113)). These sensors signal through the adaptor, IFNß 
promoter stimulator 1 (61), leading to downstream nuclear translocation of the 
transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor κB, which 
then leads to production of type I IFN.  
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IFN was first discovered as a factor which was produced in the supernatant of cells 
incubated with heat-inactivated influenza virus, and which interfered (thus the name 
interferon) with the growth of live virus when added to other cells (46). The type I IFNs 
are composed of several subtypes of IFNα, and IFNß. During type I IFN induction, 
IFNα4 and IFNß are first produced and secreted. They signal back through the IFNα/ß 
receptor on the cell surface, causing downstream signalling leading to upregulation of 
IRF7. When IFN-primed cells are exposed to viruses, they mediate a much greater type 
I IFN response as IRF7 allows the transcription of all IFNα subtypes and more 
transcription of IFNß. Downstream signalling cascades, due to engagement of the 
IFNα/ß receptor, are mediated by Janus kinases and the signal transducer and activator 
of transcription 1 (Stat1) and Stat2 proteins. The result of type I IFN signalling is 
transcriptional induction of hundreds of target genes (IFN-stimulated genes), including 
PKR, which helps cells to achieve an antiviral state (reviewed in (117)).  
 
SFV does not counter the effects of PKR at the level of PKR itself. In an SFV infected 
cell, PKR is activated and eIF2α is phosphorylated, so translation is generally inhibited, 
but the subgenomic mRNA of SFV escapes translational shut-off. In Sindbis virus 
infected cells, this same phenomenon is independent of the presence of subgenomic 
mRNA (33), suggesting that escape of translation shut-off is not simply caused by out-
competition of abundant viral mRNA over host mRNA, and that events earlier than 
subgenomic mRNA synthesis are responsible for the escape of translational shut-off by 
viral mRNA. In SFV infected cells, eIF2α phosphorylation leads to the formation of 
stress granules mediated by the RNA-binding protein T-cell-restricted intracellular 
antigen-1 ((83) and Figure 2). Stress granules are cytoplasmic complexes of mRNA and 
protein, where mRNA is stored and sorted while translation is halted, as is the case 
under stressful conditions such as heat shock. In an SFV infected cell, sequestration of 
host mRNA but not viral mRNA in stress granules partly contributes to translational 
shut-off of host but not viral mRNA. Additionally, the viral mRNA has an enhancer 
sequence which forms a hairpin loop (34), that only works as an enhancer when eIF2α 
exists mostly in the phosphorylated state (83). Host translational shut-off through 
inactivation of the eIF2 complex, formation of stress granules that sequester host 
mRNA, and enhanced translation of SFV mRNA (all dependent on eIF2α 
phosphorylation), effectively causes an SFV infected cell to become a factory for the 
synthesis of high levels of SFV structural proteins, while few host proteins are 
synthesised.  
 
After about 8 hours of productive infection, most of which are assumed to be 
concurrent with rapid type I IFN production, and the last 4 of which consist of host 
translational shut-off and high levels of SFV structural protein synthesis, SFV infected 
cells begin to die via apoptosis. While DNA viruses tend to encode pro-survival 
proteins, RNA viruses that cause acute infection and quick production of progeny do 
not need to keep their host cells alive. In the case of SFV infection, RNA replication 
triggers apoptosis by a Bcl-2 homologous antagonist/killer (Bak)-mediated loss of 
mitochondrial membrane integrity, cytochrome c release and downstream activation of 
caspases (142). Further, ER stress due to high levels of synthesis of SFV spike proteins 
plays a role in accelerating apoptosis via the activation of caspase-12. In cells infected 
with recombinant SFV lacking genes for the spike proteins, ER stress markers and 
activated caspase-12 are not present (7).  
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1.2 AUTOPHAGY 
 
1.2.1 The process of autophagy 
 
Autophagy is a lysosomal (or vacuolar, in yeast) degradation process first described in 
the budding yeast Saccharomyces cerevisiae and later discovered to be largely 
conserved through all eukaryotic cells. The two main classes of autophagy are 
chaperone-mediated autophagy, where proteins to be degraded are directly translocated 
into the lysosome with the help of chaperones (23), and macroautophagy, where 
proteins or organelles to be degraded are sequestered in double-membrane vesicles 
termed autophagosomes, which fuse with lysosomes (Figure 3, top). Within lysosomes, 
proteins are degraded by lysosomal proteases at low pH. In the field of autophagy, the 
term “autophagy” most often implies macroautophagy, and chaperone-mediated 
autophagy is referred to by its full name. The type of autophagy this thesis deals with is 
macroautophagy, hereafter “autophagy” as per convention.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Schematic diagram showing the process of autophagy. Top, a piece of membrane, termed the isolation 
membrane, is extended until it forms a double-membrane vesicle around cytoplasmic contents: the 
autophagosome. The autophagosome fuses with a lysosome containing proteases (green circles), forming 
an autolysosome where autophagic cargo is degraded by proteases. Bottom, autophagy-related 5 (Atg5), 
Atg12 and Atg16-like (Atg16L) form complexes (pink triangles) that associate with the nascent 
autophagosome membrane and recruit microtubule-associated protein light chain 3 (LC3) (purple dots). 
Atg5-12-16L subsequently dissociates from the membrane leaving LC3 associated to both the inner and 
outer membranes of the autophagosome. Adapted from (150) with permission from Elsevier.     
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The process of autophagy has been largely delineated in yeast (reviewed in (91)). A 
large number of autophagy-related (Atg) proteins, many of which are conserved 
between yeast and mammals, are involved in the autophagic process. The yeast Atg8 
protein, or the mammalian homolog microtubule-associated protein light chain 3 
(LC3), is associated with the nascent autophagosome membrane and remains 
associated with the fully formed autophagosome (Figure 3, bottom). Atg8/LC3 is thus 
the most commonly used marker for autophagosomes. 
 
Notably, Atg12 and Atg8/LC3 are ubiquitin-like proteins that are conjugated to Atg5 
and a lipid, phosphotidylethanolamine (PE), respectively. (Unlipidated LC3 and LC3-
PE are also known as LC3-I and LC3-II respectively.) The E1-like activation enzyme is 
Atg7 for both Atg12 and Atg8/LC3, while the E2-like enzyme is Atg10 and Atg3 
respectively for Atg12 and Atg8/LC3. After conjugation of Atg12 to Atg5, Atg5 
associates with Atg16-like (Atg16L) in mammalian cells. The Atg5-12-16L complex 
localises to nascent autophagosome membranes and is important for the recruitment of 
LC3-PE (Figure 3, botom). The deconjugation enzyme Atg4 can reverse Atg8/LC3-PE 
conjugation, so Atg8/LC3 can be recycled. The ubiquitin-like processes in autophagy 
are conserved between yeast (90) and mammalian (138) systems. 
 
The main function of autophagy in a normal cell is the constitutive, homeostatic 
recycling of amino acids through degradation of old or damaged proteins or organelles. 
Autophagy can be enhanced above these constitutive levels by certain stimuli, such as 
amino acid starvation. Amino acid starvation upregulates autophagy via the inactivation 
of yeast target of rapamycin (TOR) or mammalian TOR (mTOR), which represses 
autophagy under nutrient rich conditions (see section 1.3 for more on mTOR). When 
mTOR is inactive in starved mammalian cells, unc-51 like kinase 1 (ULK1, homolog 
of yeast Atg1), as part of the ULK1-Atg13-FIP200 complex, localises to forming 
autophagosome membranes. Inactivation of mTOR also causes dephosphorylation of 
ULK1 and Atg13, and promotion of ULK1 kinase activity (36, 56). Both Atg13 and 
FIP200 (focal adhesion kinase family-interacting protein of 200 kDa) enhance the 
kinase activity of ULK1 (36). ULK1 kinase activity is required for the initiation of 
autophagy (reviewed in (87)). 
 
Apart from the ULK1-mediated control of autophagy intiation, autophagy can also be 
regulated further downstream, via mammalian Beclin 1 (homolog of yeast Atg6). 
Beclin 1 binds to vacuolar protein sorting-associated protein 34 (Vps34), a class III 
PI3K involved in intracellular membrane trafficking processes. Beclin 1-Vps34 can 
further associate with either Atg14 or the UV radiation resistance associated gene 
(UVRAG) protein in a mutually exclusive manner (48). A subset of Beclin 1-Vps34-
UVRAG complex binds to RUN domain Beclin-1 interacting and cystein-rich 
containing protein (Rubicon). Association of Beclin 1-Vps34 with Atg14 promotes the 
formation of autophagosome membranes, while association with Rubicon negatively 
regulates autophagy (153). 
 
Several small molecules are used to regulate autophagy in laboratory experiments. 
Rapamycin induces autophagy by inactivating mTOR, and small molecules such as 
wortmannin, LY294002, and 3-methyladenine inhibit autophagy by inhibiting PI3K (8, 
126), although the use of PI3K inhibitors has become questionable since they may 
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inhibit both class III PI3K (which activates autophagy via Beclin 1) and class I PI3K 
(which inhibits autophagy via downstream activation of mTOR) (109, 147). 
 
Historically autophagy was referred to as a “bulk” protein degradation system, as 
substrate specificity was not well defined for autophagy compared to the specific, 
ubiquitin-mediated degradation that occurs via the other major protein degradation 
system in a cell, proteasomal degradation. Today, this view is challenged as substrates 
for autophagy are gradually characterised, even though a universal mechanism for 
targeting substrates to autophagosomes has not emerged. Substrates that have been 
described for autophagy include poly-ubiquitinated protein aggregates, targeted to 
autophagosomes via the adaptor p62/sequestosome 1 (SQSTM1) which binds both the 
aggregates and LC3 (100); cellular organelles, e.g. mitochondria (mitophagy) (4, 16), 
ribosomes (ribophagy) (69), ER (reticulophagy); and pathogens or components of 
pathogens (xenophagy) (89). Xenophagy of viruses will be discussed in section 1.2.3. 
 
1.2.2 Methods for monitoring autophagy 
 
A recent article describing assays for monitoring autophagy, and helpful guidelines, can 
be found at reference (68). I briefly discuss some of these methods to provide the 
context for the development of our novel method in Paper I.  
 
1.2.2.1 Transmission electron microscopy 
 
Transmission electron microscopy can be used to visualise autophagosomes (Figure 4). 
This method depends on identification of autophagosomes based on their double-
membrane morphology and the presence of cytoplasmic contents within the 
autophagosome.   
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Figure 4  
Transmission electron microscopy image of autophagic vacuoles in isolated mouse hepatocytes. The 
early autophagic vacuole or autophagosome (AVi) is identified by its double-membrane (arrow) and 
cytoplasmic contents, including ribosomes and rough endoplasmic reticulum (ER). The late, degradative 
autophagosome (AVd) is identified by its partially degraded contents and rough ER. Adapted from (68) 
with permission from Landes Bioscience and E.-L. Eskelinen. 
 
1.2.2.2 Western blot for LC3-II band 
 
During the process of autophagy, the autophagosome marker LC3 is converted from 
the unlipdated LC3-I form to the PE-conjugated LC3-II form (see section 1.2.1). LC3-I 
runs on an SDS-PAGE gel at an apparent molecular weight of 18 kDa, while LC3-II 
runs at 16 kDa. The ratio of the intensity of the LC3-II band to that of the LC3-I or 
actin band is used as a measurement for relative levels of the autophagosome marker 
LC3-II. In our experience, the LC3-II band is faint in cell lines where the basal amount 
of autophagosomes is low. The western blot method is not optimal for such cell lines. 
 
1.2.2.3 Fluorescence microscopy 
 
The number of LC3-positive, or enhanced green fluorescent protein (EGFP)-LC3-
positive puncta per cell, or percentage of punctate cells within a population of cells, is 
used to describe the quantity of autophagosomes. This method often depends on 
manual counting of puncta or cells, and can be both subjective and time-consuming. 
 
1.2.2.4 Flow cytometry-based detection of LC3 
 
A paper by Shvets et al. in 2008 described a method for measuring LC3 levels using 
flow cytometry (128). This method measured total LC3 levels and did not differentiate 
between LC3-I and LC3-II. The authors observed that total levels of LC3 declined as a 
cell was amino acid starved, consistent with the idea that LC3 itself is a substrate for 
autophagic degradation, thus upregulation of autophagy through starvation decreased 
the amount of LC3 over time.  
 
In Paper I of this thesis, we developed a method for quantification of autophagosomes 
that combined the high throughput capacity of flow cytometry, with the advantage of 
specific detection of LC3-II. See section 3.1 for details. 
 
1.2.2.5 Taking autophagic flux into account 
 
Autophagy is a dynamic process, involving the formation of autophagosomes, transport 
of autophagosomes to lysosomes, fusion of autophagosomes with lysosomes and 
degradation of autophagic cargo. As such, quantificaton of a steady-state number of 
autophagosomes, or a steady-state amount of an autophagosome marker, does not 
demonstrate the rate of autophagy. For example, from our experience, in a starved 
human osteosarcoma (HOS) cell compared to a non-starved HOS cell, the rate of 
autophagosome formation is increased, and the rate of autophagosome degradation 
increases along with it, resulting in a highly increased rate of autophagy (with a highly 
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increased rate of amino acid turnover), but little increase in the absolute level of LC3-
II.  
 
To circumvent this, it is possible to detect only the formation of new autophagosomes, 
by blocking the degradation of existing autophagosomes with small molecules that 
prevent lysosomal acidification. In Paper I, we demonstrated that our novel method for 
quantifying autophagy was useful for this purpose (see section 3.1).  
 
Other methods that take into account the fact that autophagosomes are constantly 
formed and degraded have been developed. One such method utilises the tandem 
reporter monomeric red fluorescent protein (mRFP)-EGFP-LC3 (67) and can tell us if 
there are changes in the degradation rate of autophagosomes. As EGFP is more 
sensitive to lysosomal acidic pH than mRFP, the mRFP-EGFP-LC3 reporter fluoresces 
yellow when it is autophagosome-bound, but fluoresces red when it has been delivered 
to lysosomes. The ratio of yellow to red puncta thus indicates levels of autophagosomes 
relative to maturing autolysosomes (autophagosomes fused with lysosomes), and 
changes in this ratio indicate changes in the fusion rate of autophagosomes with 
lysosomes. We utilised this method in Paper II to show that fusion of autophagosomes 
with lysosomes was impaired in SFV infected cells (see section 3.2). 
 
1.2.3 Autophagy and viral infection 
 
Autophagosome accumulation during viral infection has been documented in an 
increasing number of cases over the past 7 years or so. A non-exhaustive list of viruses 
that cause this phenomenon, focusing on RNA viruses, include the negative strand 
RNA viruses measles virus (53) and influenza A virus (37), and the positive strand 
RNA viruses dengue virus (101), Sindbis virus (96), Chikungunya virus (54, 55, 70), 
hepatitis C virus (HCV) (129), coronaviruses (20, 111) and poliovirus (51, 140).  
 
Sindbis virus and Chikungunya virus belong to the same genus (Alphavirus) as SFV. 
Due to their relatedness with SFV a brief description of the literature on autophagy and 
these two viral infections is in order. In Sindbis virus infected cells, the presence of 
Atg5 protects against lethal infection in the mouse central nervous system. 
p62/SQSTM1 reportedly interacts with Sindbis virus capsid protein and targets it for 
degradation in autophagosomes (96). In Chikungunya virus infected cells, levels of ER 
stress and reactive oxygen species are both increased, and both contribute to increased 
autophagic flux, with the reactive oxygen species promoting autophagy via inhibition 
of mTOR (54, 55, 70). When autophagy is inhibited through the use of 3-
methyladenine or enhanced through the use of rapamycin, Chikungunya virus 
replication decreases or increases respectively, suggesting that autophagy supports 
Chikungunya virus replication (70). 
 
While the earliest research papers on autophagy and viral infection often concluded that 
autophagy had been induced based on the observation that the number of 
autophagosomes or the amount of LC3-II had increased, more recent papers have 
distinguished between autophagosome accumulation due to autophagy induction, and 
due to blockage of lysosomal degradation of autophagosomes. For example, 
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autophagosome degradation is impaired in HCV infected cells, where autophagic 
degradation is not enhanced despite accumulation of autophagosomes (129), in 
poliovirus infected cells where autophagosomes are immobilised (139), and in 
influenza A virus infected cells where autophagosomes fail to fuse with lysosomes 
(37). 
 
In some cases, viral determinants that modulate autophagy have been identified, for 
example poliovirus 2BC protein that when expressed alone, leads to covalent 
modification of LC3 (140), coronavirus non-structural protein 6 that activates 
autophagosome formation (20), and influenza A virus matrix protein 2 that blocks 
autophagosome-lysosome fusion (37). The poliovirus 2BC and 3A proteins are 
required together, not separately, in order for double-membrane vesicles which may be 
similar to autophagosomes, to be formed (134), and the modification of LC3 by 2BC 
presumably preceeds this. Since poliovirus 2BC and 3A are membrane-associated 
proteins, it could be that their overexpression induces ER stress, which may lead to 
autophagosome accumulation (55, 129).   
 
That said, cellular mechanisms for autophagosome accumulation during viral infection 
remain largely unclear. Isolated papers report the dependence of autophagosome 
accumulation on PKR and eIF2α phosphorylation during herpes simplex virus type 1 
(HSV-1) infection (136), and on the unfolded protein response / ER stress during 
Chikungunya virus and HCV infection (55, 129). However, the unfolded protein 
response / ER stress plays no role in the autophagosome accumulation caused by 
coronavirus infection as demonstrated by analysis of ER stress markers (20).  
 
Autophagosomes may serve a proviral function in the case of the Picornaviridae family 
of viruses, since foot-and-mouth disease virus, coxsackievirus B3 and poliovirus all 
replicate more efficiently when autophagy is induced by rapamycin, and have reduced 
replication rates when autophagy is inhibited by 3-methyladenine (51, 94, 146). In foot-
and-mouth disease virus and poliovirus infections, viral replication proteins also 
colocalise with autophagosome proteins, leading to the hypothesis that picornaviruses 
use autophagosome membranes as a scaffold for assembling replication complexes. 
Interestingly, coronaviruses appear to replicate on a special type of autophagy-
independent, ER derived, LC3-I positive vesicle (112). 
 
In other instances, autophagosomes may serve an antiviral function. Notably, virions or 
viral components may be targeted for autophagic degradation in a process termed 
xenophagy. HSV-1 virions are degraded by xenophagy (136). The ICP34.5 protein of 
HSV-1 antagonises xenophagy by binding Beclin 1 (95). The capsid protein of Sindbis 
virus has also been reported to be targeted for autophagic degradation through its 
interaction with p62/SQSTM1 (96), the cellular adaptor that links ubiquitinated protein 
aggregates to LC3. (However, in this case, it is not clear whether the targeting of 
Sindbis virus capsid protein was affected by any aggregation of capsid protein, since 
the capsid protein was linked to a bulky fluorescent marker and overexpressed before 
analysis of its co-localisation with LC3.)   
 
Autophagy further contributes to the innate immune defence against viruses by helping 
plasmacytoid dendritic cells sense certain viruses. The sensor for viral single stranded 
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RNA in plasmacytoid dendritic cells is Toll-like receptor 7 (TLR7), located in 
endosomal/lysosomal compartments. UV-inactivated vesicular stomatitis virus (VSV), 
which is capable of being endocytosed but not capable of replication in the cytoplasm, 
does not activate TLR7. Live VSV is required for activation of TLR7, suggesting that 
replication intermediates in the cytoplasm are delivered to lysosomal compartments for 
sensing by TLR7. Autophagy provides this delivery system (74).  
 
Autophagy also plays a role in the presentation of endogenous antigens on major 
histocompatibility complex (MHC) class II molecules. Classically, exogenous antigens 
taken up through endocytosis are loaded onto MHC class II molecules in late 
endosomal / MHC class II loading compartments. Autophagy delivers endogenous 
antigens to the MHC class II loading compartment, and targeting an endogenous 
antigen to autophagosomes enhances MHC class II presentation of that antigen (125). 
MHC class II presentation of endogenous Epstein-Barr virus nuclear antigen 1 depends 
on autophagy (98).  
 
More recently, autophagy has also been implicated in MHC class I presentation of viral 
antigens. Autophagy has been suggested to enhance the presentation of HSV-1 antigens 
on MHC class I molecules in macrophages (29). In cells that lack transporter associated 
with antigen processing, which is necessary for the conventional MHC class I loading 
mechanism, autophagy was reported to enhance MHC class I presentation of human 
cytomegalovirus (HCMV) antigens (141). Interestingly, the autophagy process in 
melanoma cells has also been linked to enhanced cross-presentation (the presentation of 
exogenous antigens on MHC class I molecules) by dendritic cells, of antigens from the 
melanoma cells (77). Conceivably, autophagy-dependent MHC class I and class II 
presentation of virus-expressed antigens may contribute to CD8+ and CD4+ T cell 
immune surveillance, respectively. 
 
1.3 MTOR 
 
1.3.1 mTOR and rapamycin 
 
The target of rapamycin, TOR was first discovered in Saccharomyces cerevisiae when 
mutations in TOR1 and TOR2 conferred resistance to the fungicide rapamycin, 
produced by the bacterium Streptomyces hygroscopicus (45). The naturally occurring 
rapamycin is used as an immunosuppressant that can regulate T cells and promote 
tolerance to grafts (152), and has also been found to increase longevity in mice (43). 
 
The cellular receptor for rapamycin is FK506-binding protein 12 (FKBP12). The 
FKBPs are a family of immunophilins that bind immunosuppressive drugs such as 
FK506 and rapamycin (58). The mammalian counterpart of TOR, mTOR (also known 
as FKBP12-rapamycin-associated protein (FRAP), and rapamycin and FKBP12 target 
1 (RAFT1)) was identified by its binding to rapamycin-FKBP12 and was found to be 
structurally and functionally conserved with its yeast counterparts (10, 115, 116).   
 
mTOR is a large, 289 kDa serine/threonine kinase, which like the yeast TORs contains 
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a C-terminal catalytic domain with homology to phosphatidylinositol kinases, although 
no lipid kinase activity has been found for either yeast TORs or mTOR. mTOR also has 
a FKBP/rapamycin-binding domain, N-terminal to the catalytic domain, where 
rapamycin-FKBP12 binds (17). The binding of rapamycin-FKBP12 compromises 
mTOR kinase activity, reducing both its autophosphorylation (11) and its 
phosphorylation of substrates (13).  
 
1.3.2 mTORC1 and mTORC2 are functionally distinct complexes 
 
mTOR forms two distinct complexes, mTOR complex 1 (mTORC1) and mTORC2. 
mTORC1 comprises mTOR, raptor (regulatory-associated protein of TOR), mLST8 
(also known as GßL), PRAS40 and DEPTOR (32, 62, 63, 97, 108, 120). mTORC2 
comprises mTOR, rictor (rapamycin-insensitive companion of mTOR), mLST8, SIN1, 
protor and DEPTOR (49, 148). The raptor-containing mTORC1 is sensitive to 
rapamycin, whereas the rictor-containing mTORC2 is insensitive (50, 121).  
 
mTORC1 integrates various signals such as nutrient availability, presence of growth 
hormones, oxidative stress, and energy status, and controls protein synthesis and cell 
growth, by phosphorylating substrates that are involved in the protein translation 
machinery (more below). Raptor serves as a scaffold for these substrates, binding to the 
TOR signalling (TOS) motif in certain substrates (93, 123, 124, 149). 
 
The functions of mTORC2 are less well studied than those of mTORC1. mTORC2 
controls the actin cytoskeleton and cell motility (121). It has also been reported to 
phosphorylate and activate Akt, an upstream positive regulator of mTORC1, meaning 
that mTORC2 could potentially regulate mTORC1 (122).  
 
1.3.3 mTOR substrates S6K and 4E-BP1 
 
The two most well characterised substrates of mTOR are p70 S6 kinase (S6K) and 
eIF4E binding protein 1 (4E-BP1) (11, 13). S6K and 4E-BP1 interact with raptor 
through their TOS motif, which is a conserved five amino acid segment, starting with 
Phe and alternating between an acidic and a hydrophobic residue. The TOS motif in the 
N-terminus of S6K is Phe-Asp-Ile-Asp-Leu, and that in the C-terminus of 4E-BP1 is 
Phe-Glu-Met-Asp-Ile (123).  
 
Phosphorylation of S6K by mTOR activates it, allowing it to phosphorylate the 40S 
ribosomal subunit protein, S6, on five C-terminal serine residues. Phosphorylation of 
S6 is correlated with increased protein synthesis (52).  
 
Hypo-phosphorylated 4E-BP1 is a negative regulator of translation intiation: it 
sequesters eIF4E, displacing it from its interaction with eIF4G and MAP kinase signal-
integrating kinase 1 (Mnk1) in the eIF4F translation initiation complex. eIF4E 
recognises the 5’ cap structure of capped mRNA and eIF4G links mRNA to ribosomes 
(40). Mnk1 is a kinase that phosphorylates and activates eIF4E (145). Phosphorylation 
of 4E-BP1 at multiple sites, by mTOR, renders it inactive, freeing up eIF4E to bind 
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eIF4G and Mnk1, which allows for translation initiation. Phosphorylation of both S6K 
and 4E-BP1 by mTOR have the downstream effect of promoting cap-dependent 
translation (reviewed in (81)). The phosphorylation statuses of S6K/S6 and 4E-BP1 are 
commonly used as markers for mTORC1 activity. 
 
1.3.4 Activation of mTORC1  
 
mTORC1 responds to a number of different signals, including growth factors, energy 
status, hypoxia and nutrients. An important pathway for controlling mTORC1 activity 
is the class I PI3K-Akt-mTOR pathway (reviewed in (14)). Class I PI3K can be 
activated, for example, by insulin receptor substrates, in response to insulin (Figure 5). 
Class I PI3K then phosphorylates PI-4,5-bisphosphate, generating PI-3,4,5-triphosphate 
at the plasma membrane. Akt and its kinase phosphoinositide-dependent protein kinase 
1 (PDK1) are recruited by PI-3,4,5-triphosphate to the plasma membrane, where PDK1 
phosphorylates and activates Akt. Akt then inhibits the tuberous sclerosis complex 
(TSC), composed of TSC1 and TSC2. The TSC is a negative regulator of mTORC1, 
and is a GTPase activating protein that promotes the hydrolysis of Ras homolog 
enriched in brain (Rheb)-GTP to Rheb-GDP. Rheb-GTP activates mTORC1, by 
displacing the negative regulator of mTOR, FKBP38 (5, 24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5  
Schematic diagram showing the PI3K-Akt-mTOR pathway. Insulin binding to the insulin receptor leads 
to phosphorylation of insulin receptor substrates (IRS) that activate phosphatidylinositol 3-kinase (PI3K). 
PI3K phosphorylates PI-4,5-bisphosphate (PtdIns(4,5)P2) to form PI-3,4,5-triphosphate (PtdIns(3,4,5)P3) 
at the plasma membrane. Akt and phosphoinositide-dependent protein kinase 1 (PDK1) are recruited to 
the membrane by binding PtdIns(3,4,5)P3. PDK1 phosphorylates Akt on threonine 308 (T308), activating 
Akt. Akt inactivates tuberous sclerosis complex 1 (TSC1)/TSC2, promoting hydrolysis of active Ras 
homolog enriched in brain (Rheb)-GTP to inactive Rheb-GDP. Rheb-GTP activates mTOR by displacing 
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FK506-binding protein 38 (FKBP38). Hypoxia, energy depletion and amino acid depletion regulate the 
pathway at the points indicated. Adapted from (14) with permission from Nature Publishing Group and 
J.C. Alwine. 
 
The TSC is controlled not just by Akt, but also by AMP-activated kinase 
(AMPK) (66) (Figure 5). Under conditions of low energy in the cell, a high AMP to 
ATP ratio activates AMPK, which activates the TSC. Thus, mTORC1 is inactivated 
when cellular energy levels are low. mTORC1 is also inhibited under hypoxic 
conditions: hypoxia-inducible factor 1 promotes the transcription of protein regulated in 
development and DNA damage response 1, REDD1 which activates the TSC (12, 26).  
 
The presence or absence of amino acids is the most ancient regulator of mTOR, and 
controls mTOR at a point in the signalling pathway most proximal to mTOR (Figure 
5). The negative effect of amino acid depletion is dominant; insulin cannot activate 
mTORC1 if amino acids are absent (42). Amino acids promote the association of Rheb-
GTP with mTOR (79).  
 
The class III PI3K, Vps34, is a mediator of amino acid signalling to mTOR, although it 
is not known if Vps34 signals through Rheb or if it independently regulates mTORC1 
(15, 21, 92). Another mediator of amino acid signalling is a family of four Ras-related 
GTP-binding (Rag) proteins, which form heterodimers - RagA and RagB can form 
heterodimers with RagC and RagD - and interact with mTORC1 (119). The Rag 
proteins enhance the interaction of mTORC1 and Rheb, by promoting mTORC1 
translocation to lysosomal membranes that contain Rheb (118). While the expression of 
constitutively active mutants of Rag proteins causes a modest increase in S6K 
phosphorylation under nutrient rich conditions, the effect is much stronger under amino 
acid starved conditions, which suggests the involvement of Rag proteins in amino acid 
signalling (64). Consistent with the notion that Rag proteins are specifically involved in 
amino acid signalling, insulin-induced Akt phosphorylation is not affected by Rag 
proteins (64). 
 
1.3.5 mTOR and viral infection 
 
Viruses that cause acute infection often inactivate host cell cap-dependent translation 
and divert cellular protein synthesis to the synthesis of viral proteins. One way for these 
viruses to control cap-dependent translation is to modulate mTOR. For example, 
poliovirus mRNA has an internal ribosome entry site and thus does not depend on cap-
dependent translation (104, 105). In poliovirus infected cells, eIF4G is cleaved and 4E-
BP1 is dephosphorylated (41), the latter observation suggesting that mTOR is 
inactivated. In avian influenza A virus H5N1 infected cells, phospho-S6 levels are 
decreased in a TSC2-dependent manner (80), also suggesting that mTOR is inactivated. 
In cells infected with VSV, mTOR is inactivated via Akt dephosphorylation, even in 
the presence of growth factors or active PDK1. VSV matrix protein expressed alone 
leads to the dephosphorylation of Akt (25). Dephosphorylation of 4E-BP1 as a 
consequence of mTOR inactivation, in VSV infected cells, provides another pathway 
for inhibiting host cell translation apart from the phosphorylation of eIF2α (19). 
Interestingly, the inactivation of mTOR in VSV infected cells serves an antiviral 
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function that is dependent on the host stress response protein, growth arrest and DNA 
damage-inducible protein 34, GADD34 (86, 137).   
 
Chronic viruses, on the other hand, may activate mTOR as part of a strategy to keep 
host cells alive and maintain viral persistence. For example, rapamycin-sensitive 
phosphorylation of S6K and 4E-BP1 is enhanced in Huh-7 human hepatoma cells 
harboring HCV subgenomic replicons. The HCV non-structural 5A protein is 
responsible for the activation of mTOR by competitively binding the mTOR inhibitor 
FKBP38, and the activation of mTOR mediates suppression of apoptosis (106). The 
replication of HCV is in turn restricted by mTOR activity, as S6K activates an antiviral 
protein, p21-activated kinase 1 (47). The restriction of HCV replication by activated 
mTOR limits viral replication to steady-state levels (82).  
 
Another chronic virus, the DNA virus HCMV maintains mTOR activity in infected, 
amino acid starved cells, by causing Rheb and mTOR to localise to similar regions in 
the cell, in an amino acid-independent, Rag-independent, manner (18). HCMV also 
antagonises upstream negative regulation of mTOR by circumventing AMPK and TSC 
(71, 88).  
 
An interesting comparison between acute and persistent infection is illustrated by 
differential effects on mTOR activation status in Sindbis virus infected mammalian 
versus insect cells. Sindbis virus causes cytopathic and acute infection in mammalian 
cells but a less cytopathic and more persistent infection in insect cells. 4E-BP1 
phosphorylation, and cap-dependent translation, is increased in Sindbis virus infected 
mosquito, but not mammalian, cells (103). The activation of mTOR in infected insect 
but not mammalian cells may play a role in establishing Sindbis virus persistence in 
insect cells. 
 
Components of the immune response to viral infections may interact with the mTOR 
pathway. Type I IFN signalling, for example, has been shown to lead to downstream 
phosphorylation of S6K and 4E-BP1, in a manner that is dependent on the functions of 
PI3K and mTOR (75). Further, mTOR activity may play a role in supporting the 
translation of IFN-stimulated genes. For instance the induction of a key IFN-inducible 
protein, IFN-stimulated gene 15, is enhanced in 4E-BP1, TSC1 or TSC2 knockout cells 
(59). Consistent with the notion that mTOR activity may support IFN responses, 
knocking out Akt results in a dramatic reduction in IFN-induced antiviral responses 
(60).  
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2 AIMS OF THESIS 
 
2.1 GENERAL AIMS 
 
The general aim of this thesis was to better understand the roles of autophagy (Paper II) 
and mTOR (Paper III) during SFV infection. To be better equipped to study autophagy, 
we also aimed to develop a method for quantifying autophagosomes that would be 
more efficient than available methods at the time (Paper I).  
 
2.2 SPECIFIC AIMS 
 
Since autophagy promoted picornavirus replication (51, 94, 146), in Paper II we 
specifically aimed to determine whether autophagy also promoted SFV replication. 
Also, since Sindbis virus capsid protein had been reported to be targeted for xenophagy 
(96), we aimed to investigate whether any SFV proteins were targeted to 
autophagosomes. Further, we aimed to define the viral determinant responsible for the 
autophagosome accumulation that we observed in SFV infected cells. Since autophagy 
is a dynamic process involving constant synthesis and degradation of autophagosomes, 
we also aimed to decipher whether SFV-dependent autophagosome accumulation was 
the result of increased autophagy induction, or decreased autophagosome degradation.  
 
In Paper III, we aimed to define the differences in mTOR activation status in SFV 
infected versus non-infected cells, under nutrient rich and amino acid starved 
conditions. We also aimed to understand the effect of mTOR activity on SFV 
replication rate, and to pinpoint which viral components may be necessary for the 
maintenance of mTOR activity in amino acid starved cells that we observed. Further, 
we aimed to investigate the role of various components of the PI3K-Akt-mTOR 
pathway in SFV-dependent maintenance of mTOR activity. 
 
  18 
3 RESULTS AND DISCUSSION 
 
3.1 PAPER I 
 
In order to better study autophagy, we developed a novel flow cytometry-based method 
for the quantification of autophagosomes in Paper I (27). We generated a HOS cell line 
that stably expressed the EGFP-tagged autophagosome marker, EGFP-LC3. HOS-
EGFP-LC3 cells that were rinsed with low concentrations of saponin (0.05% w/v) 
became permeabilised in such a way that non-membrane-bound, cytoplasmic EGFP-
LC3-I, but not autophagosome-associated EGFP-LC3-II, was lost in the saponin wash 
(Figure 6A). The saponin rinse made it possible to specifically detect EGFP-LC3-II, 
rather than total EGFP-LC3, by flow cytometry. Since EGFP-LC3-II and not total 
EGFP-LC3 is the actual marker for autophagosomes, our novel method provided a 
means for indirectly quantifying autophagosomes through the quantification of EGFP-
LC3-II, by flow cytometry. We confirmed that the saponin rinse specifically caused the 
loss of EGFP-LC3-I, by immunofluorescence and western blot analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6  
Saponin rinse and quantification of LC3-II by flow cytometry. (A) Schematic diagram showing the 
effects of a saponin rinse. Accumulation of autophagosomes may entail a redistribution of enhanced 
green fluorescent protein (EGFP)-LC3, as cytoplasmic EGFP-LC3-I is converted to autophagosome-
associated EGFP-LC3-II (top). This does not cause changes in total levels of EGFP-LC3 (i.e. EGFP-
LC3-I + EGFP-LC3-II remains constant), and flow cytometry analysis will not differentiate between the 
EGFP fluorescence intensities of the two cells in the top half of the diagram. With a saponin rinse, 
cytoplasmic EGFP-LC3-I is extracted, while autophagosome-bound EGFP-LC3-II remains in the cell. 
This allows for differentiation between the two cells: a greater fluorescence signal will be detected in the 
cell on the bottom right than on the bottom left. (B) Flow cytometry histograms showing starvation-
induced endogenous LC3-II accumulation. Human osteosarcoma (HOS) cells were mock treated or 
treated with 50 µM chloroquine for 1 hour while simultaneously incubated in complete medium or 
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starved of amino acids and serum by incubation in Earle’s balanced salt solution (EBSS) for the last 0.5 
or 1 hour. Cells were then rinsed with saponin and stained for LC3. Previously published in (68). 
 
We amino acid starved, or chloroquine treated, HOS-EGFP-LC3 cells to influence the 
number of autophagosomes in the cell. Chloroquine is a small molecule that 
translocates into the lysosome and sequesters protons, neutralising the acidity that is 
required for lysosomal proteases to function, thus blocking autophagosome degradation 
and increasing the number of autophagosomes. We measured autophagosomes with our 
flow cytometry-based method as well as with pre-existing methods based on 
immunofluorescence or western blot analysis, and obtained comparable results across 
the different methods. Our flow cytometry-based method had the advantage of being 
less subjective, less time consuming and less labour intensive than the pre-existing 
methods.  
 
We also used our method to measure new synthesis of autophagosomes over time, by 
using ammonium chloride, NH4Cl to inhibit autophagosome degradation. NH4Cl, like 
chloroquine, blocks autophagosome degradation by neutralising lysosome acidity. We 
showed that adding NH4Cl to starved or rapamycin-treated cells allowed us to easily 
determine the levels of starvation-induced, or rapamycin-induced autophagy, with our 
flow cyometry-based method. 
 
Further, we extended our method to the detection of endogenous LC3 by incubating 
saponin-rinsed HOS cells as well as saponin-rinsed mouse embryonic fibroblasts 
(MEFs) with an LC3-specific antibody followed by a fluorescent marker conjugated 
secondary antibody. We were able to detect endogenous LC3-II in HOS cells, and in 
wild type atg5+/+ MEFs, but not in atg5-/- MEFs.  
 
Combining the above two applications of our new method, we were able to detect 
starvation-induced, endogenous LC3-II, by starving HOS cells while treating them with 
chloroquine to prevent degradation of autophagosomes, and then rinsing the cells in 
saponin before staining for LC3 (Figure 6B). 
 
Taken together, these results indicated that our novel method was useful for quick and 
non-subjective quantification of autophagosomes and analysis of autophagy induction, 
and that it had potential to be used in any cell type, transfected or non-transfected.  
 
We also observed that amino acid starvation caused little increase in EGFP-LC3-II 
levels in HOS cells unless NH4Cl was present, leading us to believe that the 
degradation rate of autophagosomes increased concurrently with autophagy induction 
rates, during amino acid starvation, in HOS cells. We speculated that HOS cells had an 
intrinsically high capacity for degradation of autophagosomes. This was instructive for 
development of ideas in Paper II about the nature of SFV-induced autophagosome 
accumulation (see next section). 
 
3.2 PAPER II  
 
In Paper II, we studied autophagy in the context of SFV infection (28). We observed 
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that autophagosomes increased up to 12 hours post infection (hpi) in SFV infected cells 
(Figure 7). This observation was aided by the method developed in Paper I (Figure 7C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7  
Autophagosomes accumulate in SFV infected cells. (A) HOS-EGFP-LC3 cells were infected with SFV. 
EGFP-LC3 positive puncta increased over time, in infected cells staining positive for SFV nsP1. (B) 
Quantification of data presented in (A). (C) Flow cytometry analysis of cells infected as in (A) or treated, 
as a positive control, with 50 µM chloroquine, showing EGFP-LC3-II accumulation in nsP1 positive cells 
but not nsP1 negative cells within the same SFV-treated sample. Previously published in (28).  
 
Questioning the role of these accumulated autophagosomes, we examined SFV 
replication rates in autophagy competent (atg5+/+) and incompetent (atg5-/-) MEFs. 
There was no difference in SFV replication rates between the two cell lines, suggesting 
that unlike the picornaviruses (51, 146), SFV did not derive a replicative advantage 
from the increased level of autophagosomes. We note that Chikungunya virus 
replication has also been reported to be enhanced by the presence of autophagosomes 
(albeit to a modest extent) (70), and we did not observe the same effect for SFV viral 
replication even though Chikungunya virus and SFV are closely related. The 
replication rate of another closely related virus, Sindbis virus is not affected by the 
presence of autophagosomes (96). 
 
We further examined whether SFV proteins were targeted to autophagosomes, since 1. 
poliovirus assembled its replication complexes on autophagosomes (51) and 2. Sindbis 
virus capsid protein was targeted for autophagic degradation via interaction with 
p62/SQSTM1 (96). We found that the nsPs and structural proteins of SFV colocalised 
either only sparingly with autophagosome markers or not at all, suggesting that SFV 
neither utilised autophagosome membranes for replication to any meaningful extent, 
nor had its components targeted for autophagic degradation. These conclusions were 
consistent with the earlier observation that viral replication rates were not affected by 
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the presence of autophagosomes.  
 
To define whether autophagosome accumulation during SFV infection was caused by 
enhanced autophagosome formation or a blockage in autophagosome degradation, we 
employed two methods. First, we assessed the activation status of mTOR, since mTOR 
is a well-known repressor of autophagy. Amino acid starvation induces autophagy by 
lifting the repression caused by mTOR, as discussed in section 1.2.1. We found that 
mTOR remained active in SFV infected cells, suggesting that at least autophagy was 
not enhanced by inactivation of mTOR during SFV infection. It remained possible at 
this point that autophagy was enhanced by other mechanisms during infection.  
 
Second, we assessed to what extent new autophagosomes were synthesised during SFV 
infection, by blocking degradation of autophagosomes with addition of NH4Cl, a 
protocol we had established in Paper I. We found that while amino acid starved cells 
accumulated a greater number of autophagosomes in the presence of NH4Cl than in its 
absence, representing starvation-induced, newly synthesised autophagosomes, SFV 
infected cells did not accumulate more autophagosomes in the presence of NH4Cl 
compared to in its absence. This suggested that the increase in autophagosomes in SFV 
infected cells was due to a blockage in autophagosome degradation, rather than 
enhanced formation of new autophagosomes.  
 
Since we had observed in Paper I that the degradation capacity for autophagosomes 
was high in HOS cells and an increase in the formation rate of autophagosomes (due to 
starvation or other factors) was not likely to lead to observable increases in LC3-II 
levels without addition of autophagosome degradation inhibitors, it was not surprising 
that SFV infection, which alone caused a substantial observable increase in LC3-II, 
caused autophagosome accumulation by blocking autophagosome degradation. 
 
To confirm that autophagosome degradation was impaired in SFV infected cells, we 
made use of the tandem reporter mRFP-EGFP-LC3 (67). Since EGFP is more sensitive 
to acidic conditions than mRFP, the mRFP-EGFP-LC3 loses its EGFP, but not mRFP, 
signal when it has been delivered to acidic lysosomes. The ratio of yellow 
(autophagosomes not yet fused with lysosomes) to red (autophagosomes fused with 
lysosomes where acidic pH bleached the EGFP signal) LC3 puncta was greatly 
increased in SFV infected cells compared to in mock infected cells, providing further 
evidence that autophagosome degradation was blocked in SFV infected cells. 
 
Gannagé et al. reported that the influenza A virus matrix protein 2 (M2) blocks 
autophagosome degradation (37). M2 is a proton channel, leading the authors to 
hypothesise that it was able to block acidification of lysosomes. However, inhibiting 
the proton channel function of M2 did not prevent it from causing autophagosome 
accumulation, suggesting that another function of M2 was involved. The SFV 6K 
protein has ion channel activity (84), making it possible that 6K might block 
autophagosome degradation by preventing lyosomal acidification.  
 
To define which viral components were necessary for autophagosome accumulation, 
we infected HOS-EGFP-LC3 cells with various recombinant SFV (rSFV) variants 
(Figure 8). Infection with SFV∆6K, which lacked the region encoding both 6K and 
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Transframe, caused similar autophagosome accumulaton as infection with wild type 
SFV, suggesting that neither 6K nor Transframe was the protein responsible for 
autophagosome accumulation in SFV infected cells. We observed instead that the rSFV 
variants that did not express spike proteins (SFV∆spike and SFV-ßgal), did not cause 
accumulation of autophagosomes (Figure 8). Thus we concluded that the expression of 
SFV spike proteins was necessary for the accumulation of autophagosomes observed in 
SFV infected cells. Viral RNA replication was not the causative agent of 
autophagosome accumulation, as SFV-ßgal, which has the genes for SFV structural 
proteins replaced with the gene encoding Escherichia coli ß-galactosidase, expressed 
the nsPs necessary for viral RNA replication but did not cause an accumulation of 
autophagosomes in infected cells. 	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8  
Autophagosome accumulation depends on expression of SFV spike proteins. (A) Schematic diagram 
showing the genes of recombinant SFV (rSFV) variants. SFV-ßgal lacks all SFV structural genes; in 
place of the structural genes is the gene encoding Escherichia coli ß-galactosidase. (B) Flow cytometry 
analysis of HOS-EGFP-LC3 cells infected with the rSFV variants shown in (A). Only infection with 
rSFV variants expressing SFV spike proteins caused EGFP-LC3-II accumulation. Part (B) was 
previously published in (28).  
 
A further experiment that could confirm the role of SFV spike protein expression 
would be to test if a plasmid encoding SFV spike proteins, and no other SFV proteins, 
would cause autophagosome accumulation when transfected into cells. Since we have 
not performed this experiment, we cannot claim that expression of SFV spike proteins 
is sufficient for autophagosome accumulaton, just that it is necessary. Thus, we cannot 
exclude the possibility that the effect of expression of SFV spike proteins on 
autophagosome accumulation can only be observed in an infected cell, due to 
cooperation by some other viral or cellular factor.  
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A mechanism by which expression of SFV spike proteins leads to autophagosome 
accumulation is yet to be elucidated. SFV spike proteins are synthesised in the ER at 
high levels causing ER stress (7). Since ER stress has been reported to mediate 
autophagy induction during HCV infection and Chikungunya virus infection (55, 129), 
it is possible that the expression of SFV spike proteins causes autophagosome 
accumulation via ER stress. To address this, in unpublished work we have infected 
HOS-EGFP-LC3 cells with wild type SFV or SFV-ßgal, or treated HOS-EGFP-LC3 
cells with thapsigargin. We found that the level of ER stress caused by the ER stressor 
thapsigargin far exceeded that caused by wild type SFV infection, as measured by the 
ER stress marker, spliced X-box-binding protein 1 mRNA (Figure 9). However, the 
amount of EGFP-LC3-II accumulation caused by thapsigargin treatment was far less 
than that caused by infection with wild type SFV. SFV-ßgal infection did not induce 
ER stress, as expected since spike proteins are not expressed by SFV-ßgal. The levels 
of autophagosome accumulation caused by thapsigargin treatment and caused by 
infection with the non ER stress inducing SFV-ßgal were comparable. Since there was 
a lack of correlation between ER stress levels and autophagosome accumulation in this 
experiment, we believe that even if ER stress contributes partly to SFV-dependent 
autophagosome accumulation, there must be other mechanisms involved that play a 
more important role. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9   
Comparison between SFV infection and the ER stressor thapsigargin. Left, DNA gel electrophoresis of 
cDNA reverse transcribed from X-box-binding protein 1 (Xbp-1) mRNA, from HOS-EGFP-LC3 cells 
infected with wild type SFV or SFV-ßgal, or treated with thapsigargin at 5 µM, for 6 hours. Right, 
histograms from flow cytometry analyses of HOS-EGFP-LC3 cells infected with wild type SFV or SFV-
ßgal for 14 hours, or treated with thapsigargin at 5 µM for 10 hours.  
 
3.3 PAPER III 
 
In non-published work done for Paper II, we hypothesised that if amino acid starvation 
induced autophagy and SFV infection blocked the degradation of autophagosomes, a 
larger number of autophagosomes would accumulate in cells that were both SFV 
infected and amino acid starved, than in cells that were only SFV infected. To our 
consternation, we did not observe the expected result. The amount of EGFP-LC3-II 
measured in SFV infected, amino acid starved cells was no greater than that measured 
in cells that were only SFV infected (Figure 10). 
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Figure 10  
Flow cytometry histograms showing the (lack of) effect of starvation on autophagosome accumulation in 
SFV infected cells. HOS-EGFP-LC3 cells were infected with SFV and starved by incubation in EBSS at 
1 hour post infection (hpi) or incubated in normal medium. At the indicated times, cells were harvested, 
saponin rinsed and analysed for EGFP-LC3-II by flow cytometry. SFV infected cells, both starved and 
not starved, were gated based on nsP1 positive staining.  
 
This result led us to question whether amino acid starvation induced autophagy in SFV 
infected cells as it does in non-infected cells. Starvation induces autophagy by 
inactivating mTOR. To test the effect of amino acid starvation on mTOR activity status 
in SFV infected cells, we mock infected or SFV infected HOS cells and at 4 hpi 
changed the medium to normal medium, or to Earle’s balanced salt solution (EBSS) to 
starve the cells of amino acids and serum. We lysed the cells after a further 4 hours, at 8 
hpi, and analysed the lysates. We found that although amino acid starvation led to 
dephosphorylation of mTOR, S6, and 4E-BP1 in mock infected cells as expected, it did 
not do so in SFV infected cells (Figure 11). The maintenance of mTOR activity in SFV 
infected, starved cells, explained why we did not observe starvation-induced autophagy 
in these cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11  
Western blot analysis showing maintenance of mTOR activity in SFV infected cells during amino acid 
starvation. HOS cells were mock infected or infected with SFV. At 4 hpi, cells were incubated in normal 
medium (-), or amino acid starved (S) by incubation in EBSS. After a further 4 hours, lysates were 
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obtained and analysed by western blot for the indicated proteins. Reproduced from Paper III 
(manuscript). 
 
We wondered whether the maintenance of mTOR activity in SFV infected cells played 
a role in viral growth. Since we observed that mTOR remained sensitive to rapamycin 
in SFV infected cells as evidenced by rapamycin-induced dephosphorylation of S6 in 
infected cells, we made use of rapamycin to test the effect of mTOR activity on SFV 
growth. We infected HOS cells with SFV, then mock treated or added rapamycin to the 
cells at 4 hpi, and measured the amount of progeny virus at intervals over a 48-hour 
time course. We found that SFV growth rate was not affected by rapamycin under these 
conditions.  
 
We speculated that an SFV infected cell might face a situation approaching amino acid 
starvation during the course of infection, due to the high amounts of viral proteins 
synthesised, compounded by the inhibition of autophagic degradation (Paper II), which 
would normally help to recycle amino acids in non-infected cells. Thus, suspecting that 
mTOR activity might confer a replicative advantage to SFV specifically in the event of 
amino acid starvation, we infected HOS cells with SFV and mock treated or added 
rapamycin to the cells, while simultaneously changing the medium to normal medium, 
EBSS, or mixtures of both across a gradient of normal medium: EBSS ratios. We found 
that cells incubated in EBSS produced far less progeny virus than cells incubated in 
normal medium or in a mixture of EBSS and normal medium. Rapamycin, however, 
had no effect on viral growth, whether the cells were incubated in EBSS, normal 
medium or a mixture of both. These results suggested that while the presence of amino 
acids was crucially important for SFV growth, mTOR activity was expendable. It is 
possible that the maintenance of mTOR activity might be a host defence response, for 
example by supporting the expression of IFN-stimulated genes (59, 60). Many mTOR-
dependent antiviral effects have been proposed (1, 3, 47, 86, 127, 137). 
 
The phosphorylation of eIF2α in SFV infected cells compromises mRNA translation 
but the SFV 26S subgenomic mRNA has an enhancer sequence that evades this effect 
(83). Since we found that the dephosphorylation of S6 and 4E-BP1 caused by 
rapamycin treatment had no effect on SFV growth, it seems possible that SFV 
subgenomic mRNA also circumvents low ribosomal activity and/or low concentrations 
of active eIF4F complex. It has been reported that translation of VSV mRNAs is not 
affected by low concentrations of active eIF4F complex when 4E-BP1 is 
dephosphorylated in VSV infected cells (19), an intriguing finding for a virus with 5’ 
capped mRNA, since eIF4E is the cap-recognising component of the cellular 
translation machinery.  
 
Viral replication was found to be necessary for the mTOR-activating effect observed in 
Sindbis virus infected insect cells, as infection with UV-inactivated Sindbis virus failed 
to increase phosphorylation of 4E-BP1 in these cells (103). To test whether SFV 
replication was necessary for mTOR activity maintenance in our system, we compared 
the effect of UV-inactivated SFV and non-UV-inactivated SFV. Incubation of HOS 
cells with UV-inactivated SFV, unlike with SFV, did not lead to maintenance of mTOR 
activity during amino acid starvation, suggesting that viral replication was required for 
the effect observed in SFV infected cells.  
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To define the viral determinants that caused maintenance of mTOR activity, we 
infected HOS cells with wild type SFV or SFV-ßgal. As described previously, SFV-
ßgal expresses the viral nsPs and undergoes RNA replication, but it does not express 
any viral structural proteins. The effect on mTOR activation status was similar between 
infection with wild type SFV and infection with SFV-ßgal, suggesting that expression 
of SFV structural proteins was not necessary for maintenance of mTOR activity. In 
Paper II we had showed that expression of SFV spike proteins was necessary for 
autophagosome accumulation, and we note here that the effect of SFV infection on 
mTOR activity is unrelated to the spike-dependent effect on autophagosomes. 
 
As the class I PI3K-Akt-mTOR signalling pathway plays a significant role in signal 
transduction to mTOR, we wondered if class I PI3K was involved in SFV-dependent 
maintenance of mTOR activity. We found that addition of wortmannin, a PI3K 
inhibitor, abrogated the effect of SFV on the maintenance of mTOR activity in amino 
acid starved cells. Wortmannin alone did not cause mTOR to be inactivated. This result 
suggested that a wortmannin sensitive, PI3K-dependent mechanism was involved in 
signal transduction to mTOR in SFV infected cells.  
 
Interestingly, we found that whereas wortmannin did not, LY294002, another PI3K 
inhibitor, inactivated mTOR when added alone. However, LY294002 has other targets 
than PI3Ks (39), and it is possible that the effect of LY294002 on mTOR inactivation 
occurs via these other targets.        
 
Since wortmannin can inhibit both class I and class III PI3K (99, 109), it is also 
possible that the wortmannin sensitivity of the SFV effect is not due to involvement of 
class I PI3K (via the class I PI3K-Akt-mTOR pathway), but due to involvement of 
class III PI3K. It is known that the mammalian class III PI3K is highly sensitive to 
wortmannin (109), and in particular more sensitive than its yeast counterpart (143), 
although it is not known if mammalian class III PI3K is more sensitive to wortmannin 
than class I PI3K. A potential mediator of the SFV-dependent effect could thus be the 
class III PI3K Vps34, which is normally involved in amino acid dependent activation 
of mTOR (15, 92).  
  
SFV causes acute cytopathic infection in mammalian cell lines, with extensive cell 
death and high output of progeny virus. We were surprised when SFV infection of 
mammalian cells led to maintenance of mTOR activity despite amino acid starvation, 
much like the phenotype observed with the chronic DNA virus HCMV (18). Sindbis 
virus, which is closely related to SFV, did not enhance mTOR activity above 
constitutive levels in infected mammalian cells, but it is not known whether mTOR 
activity would be maintained in these cells under conditions of amino acid starvation 
(103). To our knowledge, the work in paper III is the first documentation of an acute 
RNA virus infection that has positive effects on mTOR activity. Further studies would 
be required to shed light on the biological significance of this modulation. Also, it 
would be interesting to find out whether SFV infection renders mTOR resistant to the 
effects of other negative regulators such as energy depletion and hypoxia.  
  27 
4 CONCLUSION 
 
The development of a novel technique for measuring autophagosomes in Paper I 
provided a useful and reliable tool for studying autophagy. This technique was utilised 
to a great extent in Paper II. We also contributed a figure to the most recent “Guidelines 
for the use and interpretation of assays for monitoring autophagy” based on this 
technique (68). While not necessarily more sensitive than pre-existing methods, our 
flow cytometry-based assay is quicker and less subjective. 
 
Both autophagy and (m)TOR activity are fundamental and ancient biological processes 
conserved in all eukaryotic cells. The work done in Paper II and Paper III of this thesis 
describes aspects of these fundamental processes in SFV infected cells. Briefly, our 
findings can be summarised as follows: 
 
1. Autophagosomes accumulate in SFV infected cells 
2. The degradation of autophagosomes is impaired in SFV infected cells 
3. Expression of SFV spike proteins is necessary for the accumulation of 
autophagosomes 
4. mTOR activity is maintained in SFV infected, amino acid starved cells 
5. mTOR activity maintenance does not depend on expression of SFV structural 
proteins 
6. Inhibition of mTOR activity by rapamycin has no effect on SFV growth 
 
How the expression of SFV spike proteins mediates autophagosome accumulation, 
whether mTOR activity maintenance in SFV infected, amino acid starved cells is a 
result of a host defence mechanism, and how mTOR activity is maintained in infected, 
starved cells, remain to be elucidated. 
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